817
Views
0
CrossRef citations to date
0
Altmetric
Articles

MicroRNA-34a and E4orf4 synergistically promote apoptosis in Hela cells

ORCID Icon, , ORCID Icon, & ORCID Icon
Pages 1419-1423 | Received 26 May 2019, Accepted 24 Sep 2019, Published online: 04 Oct 2019

References

  • Mohamed MS, Mai KB, Almutairi FM, et al. Inhibitors of apoptosis: clinical implications in cancer. Apoptosis. 2017;22(12):1487–1423.
  • El-Shemi AG, Ashshi AM, Oh E, et al. Efficacy of combining ING4 and TRAIL genes in cancer-targeting gene virotherapy strategy: first evidence in preclinical hepatocellular carcinoma. Gene Ther. 2017;25(1):54–65.
  • Huang Q, Zeng Y, Lin H, et al. Transfection with livin and survivin shRNA inhibits the growth and proliferation of non-small cell lung cancer cells. Mol Med Rep. 2017;16(5):7086–7091.
  • Khan Z, Khan AA, Yadav H, et al. Survivin, a molecular target for therapeutic interventions in squamous cell carcinoma. Cell Mol Biol Lett. 2017; 22(1):8.
  • Yoshimasa S, Toshiaki N, Hidetsugu S. microRNA-34a as a therapeutic agent against human cancer. J Clin Med. 2015;4(11):1951–1959.
  • Liu K, Huang J, Xie M, et al. MIR34A regulates autophagy and apoptosis by targeting HMGB1 in the retinoblastoma cell. Autophagy. 2014;10(3):442–452.
  • Cao W, Yang W, Fan R, et al. miR-34a regulates cisplatin-induce gastric cancer cell death by modulating PI3K/AKT/survivin pathway. Tumor Biol. 2014;35(2):1287–1295.
  • Kleinberger T. Induction of cancer-specific cell death by the adenovirus E4orf4 protein. Adv Exp Med Biol. 2014;818:61–97.
  • Kleinberger T. Mechanisms of cancer cell killing by the adenovirus E4orf4 protein. Viruses. 2015;7(5):2334–2357.
  • Zhong MZ, Yan D, Zhi S. Effects to HeLa cells of the inhibition of survivin by antisense RNA. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai). 2001;33(5):547–551.
  • Kemp V, Dautzenberg IJC, Cramer SJ, et al. Characterization of a replicating expanded tropism oncolytic reovirus carrying the adenovirus E4orf4 gene. Gene Ther. 2018;25(5):331–344.
  • Rhee JK, Park O, Lee A, et al. Glycol chitosan-based fluorescent theranostic nanoagents for cancer therapy. Mar Drugs. 2014;12(12):6038–6057.
  • Wen S, Zhang J, Zhou P, et al. The anti-tumour effect of a DNA vaccine carrying a fusion gene of human VEGFR2 and IL-12. Biotechnol Biotechnol Equip. 2016;30(5):956–962.
  • Ji W, Sun B, Su C. Targeting microRNAs in cancer gene therapy. Genes 2017;8(1):21.
  • Hosseinahli N, Aghapour M, Duijf PHG, et al. Treating cancer with microRNA replacement therapy: a literature review. J Cell Physiol. 2018;233(8):5574–5588.
  • Gupta SK, Gandham RK, Sahoo AP, et al. Viral genes as oncolytic agents for cancer therapy. Cell Mol Life Sci. 2015; 72(6):1073–1094.
  • Zhang H, Tu JW, Liao YY, et al. Chitosan-conjugated lipid microbubble combined with ultrasound for efficient gene transfection. Biotechnol Biotechnol Equip. 2018;32(4):982–987.
  • Zhang H, Chen Z, Du M, et al. Enhanced gene transfection efficiency by low-dose 25 kDa polyethylenimine by the assistance of 1.8 kDa polyethylenimine. Drug Deliv. 2018;25(1):1740–1745.